胰十二指肠切除术中放置喂养管是敌是友?倾向性评分匹配分析
该研究基于NSQIP数据库2014–2017年15224例胰十二指肠切除术患者,其中1104例(7.5%)放置喂养管,经倾向性评分1:1匹配后各组880例,发现喂养管组总体并发症、主要并发症、器官/腔隙感染、再手术、胃排空延迟及住院时间均高于无喂养管组,但死亡率与再入院率无差异。
要点
- 胰十二指肠切除术中放置喂养管与总体并发症、主要并发症及再手术率升高相关。
- 喂养管组胃排空延迟发生率更高(26.8% vs 16.4%),住院时间更长(12.9 vs 11.2天)。
- 在发生胃排空延迟或术后胰瘘的患者中,喂养管未改善并发症、死亡率、住院时间或再入院率。
核心结论
- 胰十二指肠切除术中放置喂养管的患者术后并发症发生率和恢复延迟更高。
研究设计与样本
- 回顾性队列研究,使用NSQIP数据库2014–2017年15224例胰十二指肠切除术患者,其中1104例(7.5%)放置喂养管,采用倾向性评分1:1匹配后每组880例。
主要发现
- 匹配队列中喂养管组总体并发症52.2% vs 44.3%(p=0.001),主要并发症28.4% vs 22.5%(p=0.004)。
- 喂养管组器官/腔隙感染14.4% vs 10.9%(p=0.026),再手术8.6% vs 5.1%(p=0.003)。
- 喂养管组胃排空延迟26.8% vs 16.4%(p<0.001),平均住院时间12.9 vs 11.2天(p=0.001)。
- 死亡率1.7% vs 2.2%(p=0.488)和再入院率20.2% vs 17.2%(p=0.099)无差异。
- 在胃排空延迟或术后胰瘘患者中,喂养管与并发症、死亡率、住院时间或再入院率无关(p>0.05)。
临床怎么用
- 胰十二指肠切除术中应审慎评估放置喂养管的必要性,尤其对于预期无特殊营养风险的患者。
- 对于术后发生胃排空延迟或胰瘘的患者,喂养管并未显示改善结局,需个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of concomitant gastrostomy or jejunostomy feeding tube (FT) placement during pancreatoduodenectomy (PD) and its impact on patient outcomes remain controversial. METHODS: NSQIP database was surveyed for patients undergoing PD between 2014 and 2017. FT placement was identified using CPT codes. Propensity scores were used to match the two groups (1:1) on baseline characteristics and intraoperative variables including pancreas specific ones (duct size, gland texture, underlying disease, wound class, use of wound protector, drain placement, type of pancreatic reconstruction and vascular reconstruction). Outcomes were compared. Finally, a subset analyses for patients with delayed gastric emptying (DGE) or postoperative pancreatic fistula (POPF) were performed. RESULTS: Out of 15,224 PD, 1,104 (7.5%) had FT. POPF and DGE rates were 17% and 18%, respectively, for the entire cohort. Feeding jejunostomy was the most placed FT (88.2%). Patients with FT placement were more likely to be older (mean, 65.8 vs. 64.6 y), smokers (22.6% vs. 17.8%) who had preoperative weight loss (22.5% vs. 15.3%), ASA class ≥ 3 (80.8% vs. 77.5%), preoperative transfusion (1.5% vs. 0.84%), chemotherapy (22.8% vs. 17.5%), and radiation (14.5% vs. 6.8%, p < 0.05). The matched cohort included 880 patients in each group with completely balanced preoperative and intraoperative characteristics. In the matched cohort, patients with FT placement had higher overall morbidity (52.2% vs. 44.3%, p = 0.001), major morbidity (28.4% vs. 22.5%, p = 0.004), organ/space infection (14.4% vs. 10.9%, p = 0.026), re-operation (8.6% vs. 5.1%, p = 0.003), DGE (26.8% vs. 16.4%, p < 0.001), and longer mean hospital length of stay (12.9 vs. 11.2 days, p = 0.001) than those without FT. There was no difference in mortality (1.7% vs. 2.2%, p = 0.488) or readmission rate (20.2% vs. 17.2%, p = 0.099). In patients with DGE and POPF, FT placement was not associated with morbidity, mortality, length of stay, or readmission rate (p > 0.05). CONCLUSION: Patients with FT placement during PD tend to have higher postoperative morbidity and delayed recovery.
引用
- Soufi M, Al-Temimi M, Nguyen TK, et al. Friend or foe? Feeding tube placement at the time of pancreatoduodenectomy: propensity score case-matched analysis. Surg Endosc. 2021. PMID: 34165639. doi:10.1007/s00464-021-08594-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。